Development and Pilot Testing of a PHCI for Emergency Department Patients Who Decline Rapid HIV/ HCV Screening
1 other identifier
interventional
200
1 country
1
Brief Summary
The Centers for Disease Control and Prevention (CDC) recommends that emergency departments (EDs) and other health care facilities conduct HIV and HCV screening to identify and link to care those with undiagnosed infections. Screening for both infections in EDs is preferable due to: the shared overlap of some risk behaviors for HIV and HCV acquisition (e.g., drug use) the relatively high co-occurrence of these infections in some populations the more complex medical needs and worse sequelae for those co-infected, and efficiency. Although some EDs have experimented with dual HIV and HCV screening, best practices on how to conduct screening so as to maximize patient screening uptake have yet to be identified. In this pilot RCT, the investigators will examine the efficacy of the persuasive health communication intervention in convincing adult ED patients who decline rapid HIV/HCV screening to be tested for these infections. Adult ED patients who decline rapid HIV/HCV screening will be randomly assigned to the ED medical staff arm or the HIV/HCV counselor arm. Within each arm, participants further will be randomly assigned to receive the persuasive health communication intervention or to watch a CDC HIV/HCV testing brochures-based video. Following the intervention or control condition, all participants will be offered rapid HIV/HCV testing again.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Oct 2019
Shorter than P25 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2019
CompletedStudy Start
First participant enrolled
October 16, 2019
CompletedFirst Posted
Study publicly available on registry
October 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedAugust 20, 2021
November 1, 2020
1.2 years
October 16, 2019
August 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
HIV/HCV testing uptake
HIV/HCV testing will be remeasured via questionnaire following the intervention
10 minutes
Study Arms (2)
PHCI with HIV/HCV counselor
EXPERIMENTALA persuasive health communication intervention will be performed by a community HIV/HCV test counselor
PHCI with ED Medical Staff
EXPERIMENTALA persuasive health communication intervention will be performed by ED medical staff
Interventions
A persuasive health communication intervention will be performed
Eligibility Criteria
You may qualify if:
- years old
- English or Spanish speaking
You may not qualify if:
- HIV positive; HCV positive In an HIV vaccine trial
- On HIV pre-exposure prophylaxis medication
- In an HIV or HCV testing study
- Tested for HIV AND HCV within the past year (per EMR(Electronic Medical Record) review and patient report)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rhode Island Hospital
Providence, Rhode Island, 02907, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2019
First Posted
October 23, 2019
Study Start
October 16, 2019
Primary Completion
January 1, 2021
Study Completion
January 1, 2021
Last Updated
August 20, 2021
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share